You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Direct acting antiviral agents

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Treatment of Hepatitis c by Using Direct-acting Antiviral

Not yet recruiting
  • Hepatitis C
  • Direct Acting Antivirals
  • (no location specified)
May 9, 2022

Direct-acting Antiviral Agents on HCV Cognitive Function, and

Recruiting
  • Depression in Chronic Hepatitis C
  • Depression and Cognitive Tests
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Sep 26, 2021

Effect of DAAs on Behavior of HCC in HCV Patients

Completed
  • Carcinoma, Hepatocellular
  • Hepatitis C
    • Cairo, Egypt
    • +2 more
    Jul 19, 2021

    Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

    Recruiting
    • Chronic Hepatitis C Infection
      • Beijing, Beijing, China
      • +2 more
      Aug 27, 2021

      Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

      Recruiting
      • Chronic Hepatitis C Infection
      • PR4 + LDV/SOF + ASV 4 wk
      • +7 more
      • Beijing, Beijing, China
      • +1 more
      Aug 27, 2021

      HCV RAS Testing in Public Health Programs

      Unknown status
      • Hepatitis C
      • +3 more
      • Direct Acting Antivirals
      • Chandigarh, India
      • +1 more
      Jan 22, 2020

      HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],

      Completed
      Has Results
      • HCV Coinfection
      • +2 more
      • Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
      • Sofosbuvir/Velpatasvir (SOF/VEL)
      • Baltimore, Maryland
        Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
      Feb 10, 2022

      Direct-acting Antiviral Drugs in Treatment of Hepatitis C in

      Completed
      • Inflammatory Bowel Diseases
      • Hepatitis C Virus Infection
      • Assess the effectiveness and safety of DAAs in patients with IBD.
      • +2 more
      • Terrassa, Barcelona, Spain
        Hospital Universitari Mutua Terrassa
      Jul 8, 2022

      Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

      Not yet recruiting
      • Liver Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 9, 2023

      Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)

      Recruiting
      • Chronic Hepatitis c
      • lipid profile
      • +2 more
      • Assiut, Egypt
        Assiut University hospital
      Feb 23, 2022

      Frequency of Anxiety and Depression in Chronic Hepatitis C

      Unknown status
      • Chronic Hepatitis c
      • Direct Acting Antivirals
      • (no location specified)
      Jul 5, 2019

      Patterns of Liver Diseases Related Admissions After Era of DAAS

      Not yet recruiting
      • Patternsof Liver Diseasesadmissions After Era of DAAS
      • liver diseases admissions
      • (no location specified)
      Mar 10, 2022

      Hepatitis C Trial in Be'er Sheva, Petah Tikva (Direct acting anti-viral agents)

      Completed
      • Hepatitis C
      • Direct acting anti-viral agents
      • Be'er Sheva, Israel
      • +1 more
      Feb 17, 2021

      Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection

      Completed
      • Hepatitis B
        • Bethesda, Maryland
          National Institute of Diabetes and Digestive and Kidney Disorder
        May 29, 2019

        Hepatitis C Trial in Tanta (Sofosbuvir and Daklatasuvir)

        Recruiting
        • Hepatitis C
        • Sofosbuvir and Daklatasuvir
        • Tanta, Egypt
          Sherief Abd-Elsalam
        Oct 20, 2020

        Possible Differences in HCC Course Depending on DAA Treatment

        Recruiting
        • Carcinoma, Hepatocellular
        • +5 more
        • Direct Acting Antivirals
        • Warsaw, Mazowieckie, Poland
          Medical University of Warsaw
        May 11, 2022

        Long Term Follow up of Chronic HCV Patients Receiving DAAS

        Recruiting
        • Chronic Hepatitis c
          • Sohag, Egypt
            Sohag University Hospital
          Jun 29, 2022

          Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

          Completed
          • Chronic Hepatitis C Infection
          • +2 more
          • Hong Kong, Hong Kong, China
            Humanity and Health GI and Liver Centre
          Aug 27, 2021

          Different Antiviral Regimens for Hepatitis C Virus Relapse

          Unknown status
          • Hepatitis C
          • +2 more
          • directly acting antivirals
          • Alexandria, Egypt
            Alexandria University.
          Dec 4, 2020

          Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

          Terminated
          • Hepatitis C Virus Infection
          • Sofosbuvir (SOF)
          • +3 more
          • Phoenix, Arizona
          • +50 more
          Jan 25, 2023

          Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)

          Recruiting
          • Kidney Failure
          • +2 more
          • Glecaprevir and Pibrentasvir
          • Boston, Massachusetts
            Massachusetts General Hospital
          Jun 4, 2021

          Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

          Not yet recruiting
          • Hepatitis C
          • Cirrhosis
          • (no location specified)
          Jul 20, 2022

          HCV Trial in United States (Prophylaxis (P2W), Transmit and Treat (T&T))

          Not yet recruiting
          • HCV
          • Prophylaxis (P2W)
          • Transmit and Treat (T&T)
          • New Orleans, Louisiana
          • +5 more
          Dec 6, 2022

          HCV-TARGET- Hepatitis C Therapeutic Registry and Research

          Active, not recruiting
          • Hepatitis C
            • Phoenix, Arizona
            • +59 more
            Oct 5, 2022